Senators deem Mylan’s generic EpiPen a temporary solution | MD Anderson points to Epic implementation for 77% drop in adjusted income | The rise of the unbranded drug ad | Roche’s Zika test earns FDA emergency use authorization


From: Becker's Supply Chain Report <editorial@beckershealthcare.com>
Subject: Senators deem Mylan's generic EpiPen a temporary solution | MD Anderson points to Epic implementation for 77% drop in adjusted income | The rise of the unbranded drug ad | Roche's Zika test earns FDA emergency use authorization
Preheader:
Reply: editorial@beckershealthcare.com

View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube
Aug. 31, 2016

TODAY'S TOP STORIES
1. Senators say Mylan's discount program, generic EpiPen only temporary solution  Full story

2.

Roche's Zika test earns FDA emergency use authorization  

Full story


3.

The rise of the unbranded drug ad: 5 things to know

 


4. Upcoming webinar: Healthcare Turnover - The Cost, the Causes, and a Sustainable Solution  


 

 

5. MD Anderson points to Epic implementation for 77% drop in adjusted income  


6. 2,517 US Zika cases found across all but 2 states  

7. Upcoming webinar: Complicated, Costly and Common - The top high-cost, high-mortality procedures and how to manage them  


8. Ex-Turing CEO Martin Shkreli injects himself into EpiPen debate, defends price hike  


9.

House Committee requests documents on EpiPen price hikes from Mylan CEO

 


10. FDA approves new flu vaccine 


11. FDA fast tracks experimental drug to treat Parkinson's

  

12.

UPMC gets financial boost from insurance division  

Full story


Call for submissions - "Supply chain tip of the week": If you would like to contribute a tip, insight or best practice related to improving the hospital supply chain, please email Mackenzie Bean at
.

Channels
Integration & Physician Issues
Accountable Care Organizations
Leadership & Management
Executive Moves
Financial Management
ICD-10
Compensation Issues
Transactions & Valuation Issues
Legal & Regulatory Issues
Health Information Technology
Patient Flow
Infection Control & Clinical Quality
Supply Chain
Lists
_____________________
Contact Us

Editorial Contact: 
Molly Gamble 
Editor-in-Chief
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO

______________________

 

 
Becker's Hospital Review
A Becker's Healthcare Publication
  www.BeckersHospitalReview.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601

Copyright © 2014. All Rights Reserved.
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
SafeUnsubscribe™ {recipient's email}
Forward this email | Update Profile | About our service provider
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact